AMPH – amphastar pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Why Amphastar Pharmaceuticals (AMPH) Shares Are Sliding Today [Yahoo! Finance]
Amphastar Pharmaceuticals (AMPH): Buy, Sell, or Hold Post Q4 Earnings? [Yahoo! Finance]
Amphastar Pharmaceuticals (AMPH) had its "hold" rating reaffirmed by Jefferies Financial Group Inc.. They now have a $22.00 price target on the stock.
Amphastar Pharmaceuticals Highlights Baqsimi Milestones, Primatene Growth at Needham Conference [Yahoo! Finance]
Amphastar Pharmaceuticals (AMPH) was downgraded by Weiss Ratings from "hold (c-)" to "sell (d+)".
Form ARS Amphastar Pharmaceutical For: Dec 31
Form DEFA14A Amphastar Pharmaceutical
Form DEF 14A Amphastar Pharmaceutical For: Jun 01
Form SCHEDULE 13G/A Amphastar Pharmaceutical Filed by: VANGUARD GROUP INC
Form 4 Amphastar Pharmaceutical For: Mar 15 Filed by: Liawatidewi Yakob
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.